Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by Vejle Hospital
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT01690598
First received: September 17, 2012
Last updated: December 6, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)